Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CKD-516 plus Irinotecan in Advanced Colorectal Cancer
NCT03076957Phase 2Unknown
- Sponsor
- Chong Kun Dang Holdings
- Start
- Dec 2016
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of valecobulin in colorectal cancer (CRC), sponsored by Chong Kun Dang Holdings. Status: unknown.
02
Drugs
valecobulin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03076957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03076957.